Chronic Inflammation
37
7
8
15
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.8%
4 terminated out of 37 trials
78.9%
-7.6% vs benchmark
14%
5 trials in Phase 3/4
33%
5 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (37)
Impact of Passive Heat on Metabolic, Inflammatory and Vascular Health in Persons With Spinal Cord Injury
Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes
The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation
MicroRNA Regulation of Chronic Inflammation During Aging
Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV
The Predictive Role of Preoperative Pentraxin-3 (PTX3) in Metabolic and Inflammatory Outcomes After Roux-en-Y Gastric Bypass
Pilot Study of the Human Metagenome in Metabolic Diseases
Periodic Fasting for Treatment of Long Covid in Adults: a Pilot Study
Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)
PERCI- Medium Cut Off (MCO)
Gulf War Illness Inflammation Reduction Trial
Exploring the Effects of Antihypertensive and Lipid-Lowering Drugs on Inflammatory Cytokine Levels
2021 PMT iAge® Intervention Trial by Edifice Health
Colchicine in Patients with Heart Failure with Preserved Ejection Fraction and Inflammation
30-to-90 Day Challenge: Effects of Alcohol Cessation on Health Outcomes
To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases
Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV
PatientSpot Formerly Known as ArthritisPower